CHICAGO: A key difference between the way immune cells attack bacteria and the way antibiotics do may provide a roadmap for combating the rising threat of drug-resistant pathogens.
Researchers of the University of Michigan (UM), in collaboration with colleagues at Harvard University, have discovered that while drugs typically attack a single process within bacteria, T cells attack a host of processes at the same time.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.